International Perspectives on the AHA/ACC/SCAI Coronary Revascularization Guideline—A CTSNet Webinar (Recording)

Across the globe, coronary artery disease is a leading cause of morbidity and mortality. In December 2021, the American Heart Association (AHA), American College of Cardiology (ACC), and Society for Cardiovascular Angiography and Interventions (SCAI) released a new coronary artery revascularization guideline.

While the American Association of Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) initially participated in the development of the guideline, both organizations ultimately decided not to endorse it. Several other cardiothoracic surgery societies from around the world echoed the concerns of AATS and STS that the new guideline downgraded coronary artery bypass grafting in improving survival in patients with three-vessel coronary artery disease and normal left ventricular function, and didn’t recognize the benefits of CABG compared to PCI in decreasing late ischemic events and the COR-1 of radial artery grafting.  

In this webinar, moderator Marjan Jahangiri and representatives from AATS, STS, the European Association for Cardio-Thoracic Surgery (EACTS), Latin American Association for Cardiac and Endovascular Surgery (LACES), and the Japanese Association for Coronary Artery Surgery (JACAS) discussed: 

• Their societies’ lack of endorsement of the new the ACC/AHA/SCAI coronary revascularization guideline 
• The potential impact of the new guideline on patient care globally 
• What the global cardiothoracic surgery community can do when confronted with new guidelines that it feels do not serve the best interests of patients 
• How the guideline-development processes can be improved around the world to utilize the best science and reflect the balanced input of surgeons and cardiologists 

We hope you enjoy this webinar brought to you by CTSNet.